References
- Berka C, Meghdadi A, Smith S, Rupp G, Levendowski DJ, McConnell M, Hamilton J, Salat DH, Westbrook P. 2019. Mapping the trajectory of neurodegenerative disease with neurophysiological biomarkers acquired during sleep and waking. Paper presented at: the 14th International Conference on Alzheimer’s & Parkinson’s Diseases; Lisbon, Portugal, March 26.
- Brown T, Spurgin A, Milavetz G, Gaffney G, Johnson R. 2015. Do drowsy driver drugs differ? 8th International Driving Symposium on Human Factors in Driver Assessment, Training, and Vehicle Design; Park City, UT, June 22–25, 2015.
- Brown TL, Milavetz G, Gaffney G, Spurgin A. 2018. Evaluating drugged driving: effects of exemplar pain and anxiety medications. Traffic Inj Prev. 19(sup1):S97–S103.
- Delorme A, Makeig S. 2004. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods. 134(1):9–21.
- Gruber SA, Sagar KA, Dahlgren MK, Racine M, Lukas S. 2012. Age of onset of marijuana use and executive function. Psychol Addict Behav. 26(3):496–506.
- Gruber SA, Sagar KA, Dahlgren MK, Racine MT, Smith RT, Lukas S. 2016. Splendor in the grass? A pilot study assessing the impact of medical marijuana on executive function. Front Pharmacol. 7:355.
- McDonald AD, Schwarz C, Lee JD, Brown TL. 2012. Real-time detection of drowsiness related lane departures using steering wheel angle. Paper presented at: Human Factors and Ergonomics Society 56th Annual Meeting, Boston, MA.
- Pion-Tonachini L, Kreutz-Delgado K, Makeig S. 2019. ICLabel: an automated electroencephalographic independent component classifier, dataset, and website. arXiv Preprint.
- Ramaekers JG, Kauert G, van Ruitenbeek P, Theunissen EL, Schneider E, Moeller M. 2006. High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology. 31(10):2296–2303.
- Smith S, Stone B, Meghdadi A, Spurgin A, Brown T, Berka C. 2018. Neurophysiological indices of cannabis and impairment. Society for Neuroscience, 3–7 November, SanDiego, CA.
- Waninger S, Berka C, Meghdadi A, Karic MS, Stevens K, Aguero C, Sitnikova T, Salat DH, Verma A. 2018. Event-related potentials during sustained attention and memory tasks: utility as biomarkers for mild cognitive impairment. Alzheimers Dement (Amst). 10:452–460.
- Wesnes K, Annas P, Edgar C, Deeprose C, Karlsten R, Philipp A, Kalliomäki J, Segerdahl M. 2010. Nabilone produces marked impairments to cognitive function and changes in subjective state in healthy volunteers. J Psychopharmacol. 24(11):1659–1669.